vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and WisdomTree, Inc. (WT). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $147.4M, roughly 1.0× WisdomTree, Inc.). WisdomTree, Inc. runs the higher net margin — 27.1% vs -21.1%, a 48.2% gap on every dollar of revenue. On growth, WisdomTree, Inc. posted the faster year-over-year revenue change (33.2% vs -19.2%). WisdomTree, Inc. produced more free cash flow last quarter ($147.7M vs $-28.6M). Over the past eight quarters, WisdomTree, Inc.'s revenue compounded faster (23.4% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

WisdomTree, Inc. is a global exchange-traded fund (ETF) and exchange-traded product (ETP) sponsor and asset manager with headquarters in New York. WisdomTree launched its first ETFs in June 2006, and became one of the major ETF providers in the United States. WisdomTree sponsors different ETFs that span asset classes and countries worldwide. Categories include: U.S. and International Equity, Currency, Fixed Income and Alternatives.

OPK vs WT — Head-to-Head

Bigger by revenue
OPK
OPK
1.0× larger
OPK
$148.5M
$147.4M
WT
Growing faster (revenue YoY)
WT
WT
+52.3% gap
WT
33.2%
-19.2%
OPK
Higher net margin
WT
WT
48.2% more per $
WT
27.1%
-21.1%
OPK
More free cash flow
WT
WT
$176.3M more FCF
WT
$147.7M
$-28.6M
OPK
Faster 2-yr revenue CAGR
WT
WT
Annualised
WT
23.4%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPK
OPK
WT
WT
Revenue
$148.5M
$147.4M
Net Profit
$-31.3M
$40.0M
Gross Margin
43.1%
Operating Margin
-25.8%
40.5%
Net Margin
-21.1%
27.1%
Revenue YoY
-19.2%
33.2%
Net Profit YoY
-322.8%
46.6%
EPS (diluted)
$-0.04
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
WT
WT
Q4 25
$148.5M
$147.4M
Q3 25
$151.7M
$125.6M
Q2 25
$156.8M
$112.6M
Q1 25
$150.0M
$108.1M
Q4 24
$183.6M
$110.7M
Q3 24
$173.6M
$113.2M
Q2 24
$182.2M
$107.0M
Q1 24
$173.7M
$96.8M
Net Profit
OPK
OPK
WT
WT
Q4 25
$-31.3M
$40.0M
Q3 25
$21.6M
$19.7M
Q2 25
$-148.4M
$24.8M
Q1 25
$-67.6M
$24.6M
Q4 24
$14.0M
$27.3M
Q3 24
$24.9M
$-4.5M
Q2 24
$-10.3M
$21.8M
Q1 24
$-81.8M
$22.1M
Gross Margin
OPK
OPK
WT
WT
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Q1 24
24.2%
Operating Margin
OPK
OPK
WT
WT
Q4 25
-25.8%
40.5%
Q3 25
31.7%
36.3%
Q2 25
-38.3%
30.8%
Q1 25
-44.8%
31.6%
Q4 24
-18.0%
31.7%
Q3 24
8.2%
36.0%
Q2 24
-33.9%
31.3%
Q1 24
-41.2%
28.9%
Net Margin
OPK
OPK
WT
WT
Q4 25
-21.1%
27.1%
Q3 25
14.3%
15.7%
Q2 25
-94.7%
22.0%
Q1 25
-45.1%
22.8%
Q4 24
7.6%
24.7%
Q3 24
14.3%
-4.0%
Q2 24
-5.7%
20.3%
Q1 24
-47.1%
22.8%
EPS (diluted)
OPK
OPK
WT
WT
Q4 25
$-0.04
$0.28
Q3 25
$0.03
$0.13
Q2 25
$-0.19
$0.17
Q1 25
$-0.10
$0.17
Q4 24
$0.02
$0.20
Q3 24
$0.03
$-0.13
Q2 24
$-0.01
$0.13
Q1 24
$-0.12
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
WT
WT
Cash + ST InvestmentsLiquidity on hand
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$413.7M
Total Assets
$1.9B
$1.5B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
WT
WT
Q4 25
$364.4M
Q3 25
$412.0M
Q2 25
$267.3M
Q1 25
$428.8M
Q4 24
$426.6M
Q3 24
$400.1M
Q2 24
$40.6M
$132.5M
Q1 24
$75.6M
$116.9M
Total Debt
OPK
OPK
WT
WT
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
OPK
OPK
WT
WT
Q4 25
$1.3B
$413.7M
Q3 25
$1.3B
$373.4M
Q2 25
$1.3B
$445.1M
Q1 25
$1.3B
$415.6M
Q4 24
$1.4B
$400.0M
Q3 24
$1.4B
$374.9M
Q2 24
$1.4B
$445.6M
Q1 24
$1.3B
$423.2M
Total Assets
OPK
OPK
WT
WT
Q4 25
$1.9B
$1.5B
Q3 25
$2.0B
$1.4B
Q2 25
$2.0B
$1.1B
Q1 25
$2.1B
$1.0B
Q4 24
$2.2B
$1.0B
Q3 24
$2.3B
$1.0B
Q2 24
$2.0B
$964.1M
Q1 24
$2.0B
$931.7M
Debt / Equity
OPK
OPK
WT
WT
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
WT
WT
Operating Cash FlowLast quarter
$-25.9M
$147.9M
Free Cash FlowOCF − Capex
$-28.6M
$147.7M
FCF MarginFCF / Revenue
-19.3%
100.2%
Capex IntensityCapex / Revenue
1.8%
0.1%
Cash ConversionOCF / Net Profit
3.70×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$240.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
WT
WT
Q4 25
$-25.9M
$147.9M
Q3 25
$-34.6M
$48.1M
Q2 25
$-83.4M
$38.8M
Q1 25
$-34.6M
$6.4M
Q4 24
$-44.4M
$113.5M
Q3 24
$-77.1M
$47.7M
Q2 24
$-26.4M
$32.2M
Q1 24
$-35.6M
$-1.0M
Free Cash Flow
OPK
OPK
WT
WT
Q4 25
$-28.6M
$147.7M
Q3 25
$-37.8M
$48.0M
Q2 25
$-86.7M
$38.7M
Q1 25
$-37.7M
$6.3M
Q4 24
$-49.8M
$113.3M
Q3 24
$-85.0M
$47.7M
Q2 24
$-33.7M
$32.2M
Q1 24
$-40.0M
$-1.1M
FCF Margin
OPK
OPK
WT
WT
Q4 25
-19.3%
100.2%
Q3 25
-24.9%
38.2%
Q2 25
-55.3%
34.4%
Q1 25
-25.2%
5.9%
Q4 24
-27.1%
102.4%
Q3 24
-49.0%
42.1%
Q2 24
-18.5%
30.1%
Q1 24
-23.0%
-1.1%
Capex Intensity
OPK
OPK
WT
WT
Q4 25
1.8%
0.1%
Q3 25
2.1%
0.0%
Q2 25
2.1%
0.1%
Q1 25
2.1%
0.0%
Q4 24
2.9%
0.1%
Q3 24
4.6%
0.0%
Q2 24
4.0%
0.0%
Q1 24
2.6%
0.1%
Cash Conversion
OPK
OPK
WT
WT
Q4 25
3.70×
Q3 25
-1.60×
2.44×
Q2 25
1.57×
Q1 25
0.26×
Q4 24
-3.17×
4.15×
Q3 24
-3.10×
Q2 24
1.48×
Q1 24
-0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

WT
WT

Investment Advisory Management And Administrative Service$122.7M83%
Other Services Income$12.7M9%
IE$11.5M8%

Related Comparisons